Second, a cut-off value could not be defined for CK-18 M30 and MMP-2 levels.In conclusion, our study indicated that CK-18 M30 and MMP-2 levels are higher in CHB patients compared to healthy controls and are associated with significant hepatic fibrosis, especially cirrhosis. This evidence concerns the gene MMP2 and Hepatic fibrosis.